Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
4000
Trial Sponsor
Clinical Trial Start Date
2003
0Study Completion Date
2005
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Interventional Trial Phase
Phase 20
Phase 30
Last Updated
April 22, 2008
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Double0
Study summary
The present research program is proposed deepening some pharmacological effects of the genistein therapy in order to individualize alternative treatments to the conventional hormonal replacement therapy useful to reduce the cardiovascular morbidity and mortality and the osteoporotic consequences in postmenopausal women.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
